Corlieve Therapeutics closed a Seed round (amount undisclosed) in Nov 2020. The company is based in Paris, France. Investors in the round: IDInvest Partners, Kurma Partners, Pureos Bioventures. Data as of Nov 2026.
Amount raised
—
undisclosed
Native amount
—
Stage
Seed
seed
Investors
3
Provenance & confidence
UnverifiedAmount
Amount undisclosed or unconverted.
Unverified
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
3 namedDate
Nov 2020
Round type
seed
Amount (EUR)
—
Other rounds
same companyThis is the company's only recorded round.